| Ticker Details |
Myomo Inc.
Myomo Inc is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces.
|
| IPO Date: |
June 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$40.18M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 4.06%
|
| Avg Daily Range (30 D): |
$0.04 | 4.20%
|
| Avg Daily Range (90 D): |
$0.03 | 3.94%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.41M |
| Avg Daily Volume (30 D): |
.38M |
| Avg Daily Volume (90 D): |
.4M |
| Trade Size |
| Avg Trade Size (Sh.): |
247 |
| Avg Trade Size (Sh.) (30 D): |
229 |
| Avg Trade Size (Sh.) (90 D): |
232 |
| Institutional Trades |
| Total Institutional Trades: |
11 |
| Avg Institutional Trade: |
$1.29M |
| Avg Institutional Trade (30 D): |
$.63M |
| Avg Institutional Trade (90 D): |
$.63M |
| Avg Institutional Trade Volume: |
.43M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.81M |
| Avg Closing Trade (30 D): |
$6.14M |
| Avg Closing Trade (90 D): |
$6.14M |
| Avg Closing Volume: |
613.68K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.36
|
$-.07
|
$-.09
|
|
Diluted EPS
|
$-.36
|
$-.07
|
$-.09
|
|
Revenue
|
$41.21M
|
$10.11M
|
$11.35M
|
|
Gross Profit
|
$27.18M
|
$6.9M
|
$7.78M
|
|
Net Income / Loss
|
$-15.12M
|
$-3.01M
|
$-3.81M
|
|
Operating Income / Loss
|
$-14.04M
|
$-3.16M
|
$-2.77M
|
|
Cost of Revenue
|
$14.03M
|
$3.21M
|
$3.57M
|
|
Net Cash Flow
|
$-5.53M
|
$M
|
$1.78M
|
|
PE Ratio
|
|
|
|
|
|
|